Articles tagged with Polio Vaccines
The CDC recommends shared clinical decision-making for some childhood vaccinations, allowing parents to choose or skip certain vaccines. However, a survey found that many Americans are unclear about what this means and who can be included as health care providers in the discussion.
A new survey by the Annenberg Public Policy Center finds a small but significant drop in the proportion of the public that would recommend getting the MMR vaccine, citing concerns over its safety and effectiveness. The survey also shows declines in perceived safety and effectiveness for other vaccines, such as seasonal flu and Covid-19.
A German study using a digital cohort dataset found that twenty percent of participants had unreported polio vaccinations, while forty percent of documented doses were unidentified. The study emphasizes the need for improved vaccine tracking and booster vaccination strategies to ensure effective population protection.
Researchers at Lancaster University discovered a new type of vaccine-specific scepticism, where some people perceive COVID-19 vaccines as 'not a vaccine' compared to MMR. This phenomenon may also apply to the flu vaccine, highlighting the need for clear public health messaging.
Researchers at the University of Leeds have developed a more affordable and lower-risk polio vaccine using virus-like particles (VLPs). VLPs mimic the outer protein shell of poliovirus but are empty inside, making them non-infectious yet capable of triggering an immune response.
The EU/EEA has detected circulating vaccine-derived poliovirus type 2 (cVDPV2) in sewage samples, prompting increased vigilance. To prevent a return of the disease, countries must maintain high vaccination rates and close vaccination gaps, as well as strengthen environmental surveillance.